The company shows stable performance with a slight decline in profit after taxation but an increase in total equity

Filed as: Financial Results for the Quarter Ended December 2025

IBLHLIBL HealthCare LimitedIBLHL · PharmaceuticalsFinancial resultFiled Pakistan time

Summary

The company shows stable performance with a slight decline in profit after taxation but an increase in total equity. Revenue remains strong.

Read the original filing

Figures in the filing

ItemThis periodPeriod beforeChange
Revenue9711470001117721000-13.1%
Gross Profit401842000334935000+20.0%
Profit after Taxation3590700040165000-10.6%
Total Assets43403890004009968000+8.2%
Total Equity24286450002323050000+4.5%

Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).

What the filing says

  • Revenue from contracts with customers decreased to Rs 971.15 million from Rs 1,117.72 million, down 13.1%.
  • Profit after taxation fell to Rs 35.91 million from Rs 40.17 million, a decline of 6.5%.
  • Total equity increased to Rs 2,428.65 million from Rs 2,323.05 million, reflecting a growth of 4.5%.

IBL HealthCare Limited (IBLHL) on Nafa

Last price Rs 41.00 · Pharmaceuticals · You can own IBLHL shares from your phone.

More IBLHL announcements

All IBLHL announcements

Source: IBL HealthCare Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.